2021
DOI: 10.12669/pjms.37.3.3664
|View full text |Cite
|
Sign up to set email alerts
|

Mobile Health Augmented Cardiac Rehabilitation (MCard) in Post-Acute Coronary Syndrome Patients: A randomised controlled trial protocol

Abstract: Objectives: To determine the effectiveness of mobile health augmented cardiac rehabilitation (MCard) on health-related quality of life (HRQoL), clinical and behavioural outcomes in post-ACS. Methods: A single-centre, single-blinded, two-arm randomised controlled trial is planned at Armed Forces Institute of Cardiology (AFIC), Pakistan. The duration was two years, that is from January 2019 till December 2020. A total of 160 participants were recruited and randomly allocated to the control group or the int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…The trial protocol in its entirety has already been published. 14 The trial is also registered in the Australian New Zealand Clinical Trial Registry (ANZCTR) (ACTRN12619001731189). 15 Data were collected at three-time points, at baseline, 12 weeks follow-up, and then at 24 weeks follow-up, by a research associate who was blinded to the group status of the enrolled participants.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The trial protocol in its entirety has already been published. 14 The trial is also registered in the Australian New Zealand Clinical Trial Registry (ANZCTR) (ACTRN12619001731189). 15 Data were collected at three-time points, at baseline, 12 weeks follow-up, and then at 24 weeks follow-up, by a research associate who was blinded to the group status of the enrolled participants.…”
Section: Methodsmentioning
confidence: 99%
“…The trial protocol in its entirety has already been published. 14 The trial is also registered in the Australian New Zealand Clinical Trial Registry (ANZCTR) (ACTRN12619001731189). 15 …”
Section: Methodsmentioning
confidence: 99%